ANNETTE ROBINSON: Open Payments
NPI 1629129390 · VALDOSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$610 in 22 payments from 11 companies in 2025. Trend: 2023 $247 · 2024 $274 · 2025 $610
Food & beverage: $610
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $167 |
| Novo Nordisk Inc | 2 | $96 |
| Axsome Therapeutics, Inc. | 3 | $70 |
| GlaxoSmithKline, LLC. | 4 | $68 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $53 |
| PFIZER INC. | 2 | $39 |
| Smith+Nephew, Inc. | 1 | $28 |
| Dexcom, Inc. | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
Products named: AIRSUPRA, Wegovy, Auvelity, CAPLYTA, TRELEGY ELLIPTA, NURTEC ODT, COLLAGENASE SANTYL, Dexcom G6 Transmitter.
Industry payments across GA — which companies pay providers there.
